These findings were supported by AD rat models showing that administration of telmisartan (an AT1 receptor blocker) can decrease TNF-α mRNA expression in the hippocampus and ameliorate spatial memory (Shindo et al., 2012). Here, AGTR1 is linked to Alzheimer disease.